|
Match
|
Document |
Document Title |
|
|
6869944 |
Method for treating a patient with neoplasia by treatment with a platinum coordination complex
This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an antineoplastic platinum coordination complex.
|
|
|
6869967 |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these...
|
|
|
6867236 |
Method of preventing of delaying the onset and progression of Alzheimer's disease and related disorders
The present invention relates, in general, to a method of preventing or delaying the onset of Alzheimer's disease and related neurodegenerative disorders. The invention also relates to a method of...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6828328 |
Analgesic combination of muscarinic agonists
This invention relates to the combination of muscarinic agonists with narcotic analgesics, non-steroidal anti-inflammatory drugs or other analgesic drugs and to their use as antinociception (pain...
|
|
|
6809118 |
Methods for therapy of radiation cutaneous syndrome
Compounds of a histone deacetylase inhibitor. The compounds are capable of simultaneously stimulating epithelium regrowth, inhibiting cutaneous fibroblast proliferation, decreasing collagen...
|
|
|
6806261 |
Methods for treating certain diseases using naaladase inhibitors
The present invention relates to methods for regulating the release of TGF-β from living cells in vitro or in vivo, comprising bringing the cells into contact with an effective amount of a...
|
|
|
6797694 |
Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca 2+ activated potassium channel (IK Ca ), and the use of such compounds for the...
|
|
|
6797728 |
Use of intracellular calcium chelators to increase surfactant secretion in the lungs
Pulmonary surfactant is required in order to reduce surface tension in the lungs so that less effort is needed to reinflate the lungs after exhalation. A number of diseases and conditions exist...
|
|
|
6794412 |
Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
Provided is a method of treating thrombosis in mammals by administering therapeutically effective amounts of a combination of (i) a Factor Xa inhibitor, and (ii) a compound selected from the group...
|
|
|
6794411 |
Drinkable ibuprofen pharmaceutical suspension
The invention relates to a drinkable ibuprofen solution wherein the soluble fraction of the active ingredient contained therein is less than 10% by weight in relation to the weight of the suspension.
|
|
|
6784209 |
Food supplement for increasing lean mass and strength
Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described...
|
|
|
6777442 |
Diphenyl derivatives
The present invention relates to compounds of the general formula (I) in which X represents O, S, SO, SO 2 , CH 2 , CHF, CF 2 or NR 8 , and Z represents a group of the formula in which A...
|
|
|
6774111 |
Carbohydrate system and a method for providing nutrition to a diabetic
The two carbohydrate mixture of this invention utilizes a source of fructose in combination with at least one readily digestible glucose polymer source. The addition of the fructose significantly...
|
|
|
6740680 |
Pharmaceutical compositions to tetrac and methods of use thereof
The present invention provides novel pharmaceutical compositions and methods of treatment that utilize or comprise tetrac and/or another thyromimetic compound. The pharmaceutical compositions of...
|
|
|
6730686 |
Methods for inhibiting oxidative modification of proteins
The instant invention provides compositions and methods for modeling post-Amadori AGE formation and the identification and characterization of effective inhibitors of post-Amadori AGE formation,...
|
|
|
6730329 |
Zinc containing compositions for anti-viral use
One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one...
|
|
|
6726929 |
Pharmaceutical mixture comprising a profen
A pharmaceutical mixture comprising a profen is described which has a profen content of over 85% and contains up to 1% of a nonionic surfactant having an HLB of ≧9 and also a customary...
|
|
|
6723749 |
Fatty acid synthase inhibitors
This invention relates to the use of compounds as inhibitors of the fatty acid synthase FabH.
|
|
|
6703421 |
Methods of using phenylmethylbenzoquinone and hydroquinone compounds for treatment of myocarditis, dilated cardiomyopathy and heart failure
A method for prevention or treating myocarditis, dilated cardiomyopathy and heart failure comprising administering to a patient in need of such treatment a NF-κB inhibitor in a therapeutically...
|
|
|
6699510 |
Acidic aqueous chlorite teat dip with improved visual indicator stability, extended shelf life, sanitizing capacity and tissue protection
The mastitis control teat dip composition having a visible indicator aspect of the invention provides a softening, soothing, smoothing, relaxing property, a rapid initial kill, a useful highly...
|
|
|
6699486 |
Treatment or prevention of photoaging and skin cancer
Disclosed herein are methods for the treatment or prevention of photoaging or skin cancer in a patient. These methods include administering a compound that inhibits a component of the kallikrein...
|
|
|
6660770 |
Pesticidal activity of functionalized alkenes
The present invention provides non-peptide organic compounds that have a structure analogous to or reminiscent of the TMOF structure and have pesticidal activity. Thus the present invention...
|
|
|
6653322 |
Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
The present invention provides compositions and methods for treating an animal, preferably a human, suffering from or predisposed to a physical disorder by administering an effective amount of a...
|
|
|
6653258 |
Hetero-aryl compounds having herbicidal, fungicidal and insecticidal activity
Fungicidal compounds of the formula (I): and stereoisomers thereof, wherein R 1 is optionally substituted aryl or optionally substituted heteroaryl; Y is oxygen, sulphur or NR 4 ; R 2 , R 3 ...
|
|
|
6646003 |
Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
The topical use of certain flurbiprofen amide derivatives and ketorolac amide derivatives to treat ophthalmic angiogenesis-related and inflammatory disorders of the posterior segment of the eye is...
|
|
|
6646005 |
Method of treating hair loss using sulfonyl thyromimetic compounds
Methods for treating hair loss using a composition including a compound having the following structure and pharmaceutically acceptable salts, hydrates, and biohydrolyzable amides, esters, and...
|
|
|
6642273 |
Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and in cosmetics
An unsaturated derivative at the 4-position of 6-tert-butyl-1,1-dimethylindane corresponding to the following formula: in which: X represents: a divalent radical of formula: and Y represents a...
|
|
|
6630600 |
3-aryl propionic acid derivatives and analogs
Novel 3-aryl propionic acid derivatives and analogs, process and intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions...
|
|
|
6627652 |
Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
Process of treatment of mammals, including humans to treat diseases or conditions of the type which are normally treated with retinoid-like compounds is disclosed, with pharmaceutical compositions...
|
|
|
6624197 |
Diphenylethylene compounds
Novel diphenylethylene and styrenes are provided which are administered orally to decrease blood glucose levels in rats. The glucose tolerance in insulin resistant rats is also shown, as well as...
|
|
|
6620853 |
Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs
Methods and compositions for the prevention and/or treatment of vascular restenosis, the methods comprising administering to individuals in need thereof, an effective amount of a non-steroidal...
|
|
|
6620851 |
Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen
Methods of treating neuropathic pain, tinnitus, and related disorders are disclosed. These methods comprise the administration of optically pure R(−)-ketoprofen. Also disclosed are pharmaceutical...
|
|
|
6608109 |
Composition comprising L-arginine as a muscle growth stimulant and use thereof
A composition for stimulating muscle growth, comprising an effective amount of L-arginine or a salt thereof, a pH control agent for controlling the pH at less than 7 and a pharmaceutically...
|
|
|
6608061 |
Bisaryl compound and medicament for cancer treatment comprising the same
A medicament for treatment of cancer comprising a compound represented by the following general formula (I) or a physiologically acceptable salt thereof: Ar 1 —S—R 1 —S—Ar 2 wherein R 1 ...
|
|
|
6608111 |
Method for treating or preventing prostatic conditions
Provided is a method comprising administering (+) -Z- bisdehydrodoisynolic acid to a patient for treating, inhibiting or delaying the onset of prostatic conditions including prostatitis, benign...
|
|
|
6596761 |
Cosmetic and dermatological preparation with flavonoids
The invention relates to cosmetic and dermatological formulations having a) a content of a compound or several compounds from the group consisting of flavonoids, or having b) a content of an...
|
|
|
6586463 |
C16 unsaturated FP-selective prostaglandins analogs
Compounds having the general structure: which are useful for the treatment of a variety of diseases and conditions, such as bone disorders.
|
|
|
6586468 |
&ohgr -substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient
A ω-substituted phenyl-prostaglandin of formula (I), a process for the preparation thereof, a mediciament comprising it as active ingredient (all symbols have the same meaning as described in the...
|
|
|
6569900 |
Fulvic acid and its use in the treatment of various conditions
Fulvic acid salts, esters or derivatives thereof in pharmaceutical preparations are effective for treating inflammation, acne, exzema or bacterial or fungal or viral infections. These...
|
|
|
6565864 |
Skin care product containing retinoids and phytoestrogens in a dual compartment package
A stable skin care product containing a first composition comprising about 0.001% to about 10% of a retinoid; a second composition comprising about 0.001% to about 10% of a phytoestrogen; a first...
|
|
|
6552077 |
Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
The present invention is directed to compositions that inhibit the nonenzymatic glycation of albumin, as well as methods of using compounds that inhibit albumin glycation for the treatment of...
|
|
|
6548546 |
HIV integrase inhibitors
The present invention relates to HIV integrase inhibitors of the formula wherein R 1 and Z are as defined in the specification.
|
|
|
6545050 |
Aryl sulphonamide amino acid esters and analogues
The present invention relates to novel amino acid esters of arylsulphonamides and analogues, to processes for their preparation and to their use for the prophylaxis and treatment of...
|
|
|
RE38071 |
Method for treating infectious respiratory diseases
A method of treating pneumonia caused by a microorganism by administering directly into the lower respiratory tract of a host an amount of an anti-inflammatory agent effective to reduce...
|
|
|
6541038 |
Method for treating wood with a metal-containing treating agent and wood treated thereby
A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion...
|
|
|
6538028 |
Method for inhibiting complement activation
A method of inhibiting complement activation, particularly by a transplanted tissue, in a warm-blooded vertebrate. The method includes administering a therapeutically effective amount of a platelet...
|
|
|
6538030 |
Treating radiation fibrosis
A method for treating a subject having radiation fibrosis is disclosed comprising topically administrating to the subject an effective amount of a compound of the formula: R 1 and R 2 ,...
|
|
|
6538011 |
Composition for the antidandruff treatment of the hair and scalp based on an antidandruff active principle and on a hydroxy acid
Cosmetic or dermatological compositions for washing and/or antidandruff treatment of hair and/or scalp comprising at least one antidandruff agent chosen from pyridinethione salts, at least 1% by...
|
|
|
6528097 |
Sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
A controlled release microcapsule pharmaceutical formulation for burst-free, sustained, programmable release of a non-steroidal, antiinflammatory drug over a duration from 24 hours to 2 months,...
|